12Dec 2022
Marked weight loss on liraglutide 3.0 mg: Real‐life experience of a Swiss cohort with obesity

Marked weight loss on liraglutide 3.0 mg: Real‐life experience of a Swiss cohort with obesity

This study investigated the effectiveness of liraglutide 3.0 mg daily in combination with a standardized multidisciplinary intervention on body weight and body composition changes in a real‐life setting. At 10 months, the mean (SD) percentage weight loss (WL%) was −12.4% (5.5%) or −14.1 (6.6) kg. WL% was ≥5% in 87% of patients at 4 months and in 96% at 10 months. In a real‐world setting, liraglutide 3.0 mg led to beneficial WL and body composition changes, with a greater impact on women.

  • #endo-diabetology

Like

Save

Share